GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -66.7% | 108 | -58.6% | 0.00% | – |
| Q1 2022 | $9,000 | -71.9% | 261 | -76.4% | 0.00% | – |
| Q4 2021 | $32,000 | +28.0% | 1,106 | +15.0% | 0.00% | – |
| Q3 2021 | $25,000 | -16.7% | 962 | +11.1% | 0.00% | – |
| Q2 2021 | $30,000 | -16.7% | 866 | -2.0% | 0.00% | – |
| Q1 2021 | $36,000 | +227.3% | 884 | +233.6% | 0.00% | – |
| Q4 2020 | $11,000 | -21.4% | 265 | +6.0% | 0.00% | – |
| Q3 2020 | $14,000 | -22.2% | 250 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | -53.8% | 250 | -68.9% | 0.00% | -100.0% |
| Q3 2019 | $39,000 | -7.1% | 805 | +0.8% | 0.00% | -50.0% |
| Q2 2019 | $42,000 | – | 799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |